{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:44:47Z","timestamp":1791603887692,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While high-level evidence is lacking, numerous retrospective studies have depicted the value of supplemental oxygen in idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases, and its use should be encouraged where necessary. The clinical course and survival of patients with IPF who have been introduced to oxygen therapy is still not fully understood. The objective of this study was to clarify overall survival, factors associated with prognosis, and causes of death in IPF patients after the start of oxygen therapy. This is a prospective cohort multicenter study, enrolling patients with IPF who started oxygen therapy at 19 hospitals with expertise in interstitial lung disease. Baseline clinical data at the start of oxygen therapy and 3-year follow-up data including death and cause of death were assessed. Factors associated with prognosis were analyzed using univariable and multivariable analyses. One hundred forty-seven eligible patients, of whom 86 (59%) were prescribed ambulatory oxygen therapy and 61 (41%) were prescribed long-term oxygen therapy, were recruited. Of them, 111 died (76%) during a median follow-up of 479\u00a0days. The median survival from the start of oxygen therapy was 537\u2009\u00b1\u200974\u00a0days. In the univariable analysis, low body mass index (BMI), low forced vital capacity (FVC), low diffusion capacity (D<jats:sub>LCO<\/jats:sub>), resting hypoxemia, short 6\u00a0min-walk distance, and high COPD assessment test (CAT) score were significantly associated with poor prognosis. Multivariable analysis revealed low BMI, low FVC, low D<jats:sub>LCO<\/jats:sub>, low minimum SpO<jats:sub>2<\/jats:sub> on 6MWT, and high CAT score were independent factors for poor prognosis. The overall survival of IPF patients after starting oxygen therapy is about 1.5 years. In addition to pulmonary function tests, 6MWT and patient reported outcomes can be used to predict prognosis more accurately.<\/jats:p><jats:p>Clinical Trial Registration: UMIN000009322.<\/jats:p>","DOI":"10.1038\/s41598-023-40508-8","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T09:01:47Z","timestamp":1692694907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy"],"prefix":"10.1038","volume":"13","author":[{"given":"Kensuke","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Akagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Kishaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinyu","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"40508_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788\u2013824 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"40508_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1183\/09031936.00106011","volume":"40","author":"M Mura","year":"2012","unstructured":"Mura, M. et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study. Eur. Respir. J. 40, 101\u2013109 (2012).","journal-title":"Eur. Respir. J."},{"key":"40508_CR3","doi-asserted-by":"publisher","first-page":"160080","DOI":"10.1183\/16000617.0080-2016","volume":"26","author":"EC Bell","year":"2017","unstructured":"Bell, E. C. et al. Oxygen therapy for interstitial lung disease: A systematic review. Eur. Respir. Rev. 26, 160080 (2017).","journal-title":"Eur. Respir. Rev."},{"key":"40508_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1513\/AnnalsATS.201702-137OI","volume":"14","author":"KA Johannson","year":"2017","unstructured":"Johannson, K. A. et al. Supplemental oxygen in interstitial lung disease: An art in need of science. Ann. Am. Thorac. Soc. 14, 1373\u20131377 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"40508_CR5","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-206865","volume":"70","author":"M Hardinge","year":"2015","unstructured":"Hardinge, M. et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax 70, i1\u2013i43 (2015).","journal-title":"Thorax"},{"key":"40508_CR6","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1164\/ajrccm.161.4.9907002","volume":"161","author":"WW Douglas","year":"2000","unstructured":"Douglas, W. W., Ryu, J. H. & Schroeder, D. R. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. Am. J. Respir. Crit. Care Med. 161, 1172\u20131178 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"40508_CR7","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","volume":"202","author":"SS Jacobs","year":"2020","unstructured":"Jacobs, S. S. et al. Home oxygen therapy for adults with chronic lung disease. An Official American Thoracic Society clinical practice guideline. Am. J. Respir. Crit. Care Med. 202, e121\u2013e141 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"40508_CR8","first-page":"CD011716","volume":"7","author":"C Sharp","year":"2016","unstructured":"Sharp, C., Adamali, H. & Millar, A. B. Ambulatory and short-burst oxygen for interstitial lung disease. Cochrane Database Syst. Rev. 7, CD011716 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"40508_CR9","first-page":"CD002883","volume":"3","author":"AJ Crockett","year":"2001","unstructured":"Crockett, A. J., Cranston, J. M. & Antic, N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst. Rev. 3, CD002883 (2001).","journal-title":"Cochrane Database Syst. Rev."},{"key":"40508_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","volume":"6","author":"D Visca","year":"2018","unstructured":"Visca, D. et al. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): A prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir. Med. 6, 759\u2013770 (2018).","journal-title":"Lancet Respir. Med."},{"key":"40508_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1513\/AnnalsATS.201611-934OC","volume":"14","author":"YH Khor","year":"2017","unstructured":"Khor, Y. H., Goh, N. S. L., McDonald, C. F. & Holland, A. E. Oxygen therapy for interstitial lung disease. A mismatch between patient expectations and experiences. Ann. Am. Thorac. Soc. 14, 888\u201395 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"40508_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.rmed.2013.05.015","volume":"107","author":"O Nishiyama","year":"2013","unstructured":"Nishiyama, O. et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir. Med. 107, 1241\u20131246 (2013).","journal-title":"Respir. Med."},{"key":"40508_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/thoraxjnl-2016-209806","volume":"73","author":"LJ Jabbarian","year":"2018","unstructured":"Jabbarian, L. J. et al. Advance care planning for patients with chronic respiratory diseases: A systematic review of preferences and practices. Thorax 73, 222\u2013230 (2018).","journal-title":"Thorax"},{"key":"40508_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley, B. et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 156, 684\u201391 (2012).","journal-title":"Ann. Intern. Med."},{"key":"40508_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8, N. et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 37, 67\u2013119 (2016).","journal-title":"Eur. Heart J."},{"key":"40508_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/resp.12936","volume":"22","author":"T Matsuda","year":"2017","unstructured":"Matsuda, T. et al. COPD assessment test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study. Respirology 22, 721\u2013727 (2017).","journal-title":"Respirology"},{"key":"40508_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1440-1843.2012.02131.x","volume":"17","author":"K Nagata","year":"2012","unstructured":"Nagata, K. et al. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology 17, 506\u2013512 (2012).","journal-title":"Respirology"},{"key":"40508_CR18","doi-asserted-by":"publisher","first-page":"15063","DOI":"10.1038\/npjpcrm.2015.63","volume":"25","author":"WC Huang","year":"2015","unstructured":"Huang, W. C., Wu, M. F., Chen, H. C., Hsu, J. Y., TOLD Group. Features of COPD patients by comparing CAT with mMRC: A retrospective, cross-sectional study. NPJ Prim. Care Respir. Med. 25, 15063 (2015).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"40508_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1378\/chest.109.3.741","volume":"109","author":"E Chailleux","year":"1996","unstructured":"Chailleux, E., Fauroux, B., Binet, F., Dautzenberg, B. & Polu, J. M. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 109, 741\u20139 (1996).","journal-title":"Chest"},{"key":"40508_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/thoraxjnl-2015-207439","volume":"71","author":"Z Ahmadi","year":"2016","unstructured":"Ahmadi, Z. et al. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study. Thorax 71, 510\u2013516 (2016).","journal-title":"Thorax"},{"key":"40508_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4187\/respcare.06615","volume":"64","author":"HA Rantala","year":"2019","unstructured":"Rantala, H. A., Leivo-Korpela, S., Lehtim\u00e4ki, L. & Lehto, J. T. Predictors of impaired survival in subjects with long-term oxygen therapy. Respir. Care 64, 1401\u20131409 (2019).","journal-title":"Respir. Care"},{"key":"40508_CR22","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.21037\/jtd.2016.12.49","volume":"8","author":"T Kishaba","year":"2016","unstructured":"Kishaba, T., Nagano, H., Nei, Y. & Yamashiro, S. Body mass index-percent forced vital capacity-respiratory hospitalization: New staging for idiopathic pulmonary fibrosis patients. J. Thorac. Dis. 8, 3596\u20133604 (2016).","journal-title":"J. Thorac. Dis."},{"key":"40508_CR23","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1378\/chest.06-2784","volume":"131","author":"M Alakhras","year":"2007","unstructured":"Alakhras, M., Decker, P. A., Nadrous, H. F., Collazo-Clavell, M. & Ryu, J. H. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest 131, 1448\u20131453 (2007).","journal-title":"Chest"},{"key":"40508_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/resp.12941","volume":"22","author":"O Nishiyama","year":"2017","unstructured":"Nishiyama, O. et al. Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis. Respirology 22, 480\u2013485 (2017).","journal-title":"Respirology"},{"key":"40508_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12931-020-01528-4","volume":"21","author":"S Jouneau","year":"2020","unstructured":"Jouneau, S. et al. Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis. Respir. Res. 21, 312 (2020).","journal-title":"Respir. Res."},{"key":"40508_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1378\/chest.129.3.746","volume":"129","author":"CJ Lettieri","year":"2006","unstructured":"Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S. & Shorr, A. F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129, 746\u2013752 (2006).","journal-title":"Chest"},{"key":"40508_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00408-015-9767-x","volume":"193","author":"D Bennett","year":"2015","unstructured":"Bennett, D. et al. Mortality on the waiting list for lung transplantation in patients with idiopathic pulmonary fibrosis: A single-centre experience. Lung 193, 677\u2013681 (2015).","journal-title":"Lung"},{"key":"40508_CR28","doi-asserted-by":"publisher","first-page":"v423","DOI":"10.1111\/j.1445-5994.2006.01103.x","volume":"v36","author":"A Reed","year":"2006","unstructured":"Reed, A., Snell, G. I., McLean, C. & Williams, T. J. Outcomes of patients with interstitial lung disease referred for lung transplant assessment. Intern. Med. J. v36, v423-430 (2006).","journal-title":"Intern. Med. J."},{"key":"40508_CR29","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1164\/rccm.200302-219OC","volume":"168","author":"VN Lama","year":"2003","unstructured":"Lama, V. N. et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 168, 1084\u20131090 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"40508_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/jcm5080073","volume":"18","author":"B Vainshelboim","year":"2016","unstructured":"Vainshelboim, B., Kramer, M. R., Izhakian, S., Lima, R. M. & Oliveira, J. Physical activity and exertional desaturation are associated with mortality in idiopathic pulmonary fibrosis. J. Clin. Med. 18(5), 73 (2016).","journal-title":"J. Clin. Med."},{"key":"40508_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12931-017-0503-3","volume":"18","author":"T Furukawa","year":"2017","unstructured":"Furukawa, T. et al. The St. George\u2019s respiratory questionnaire as a prognostic factor in IPF. Respir. Res. 18, 18 (2017).","journal-title":"Respir. Res."},{"key":"40508_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1513\/AnnalsATS.201906-437OC","volume":"17","author":"AH Case","year":"2020","unstructured":"Case, A. H. et al. Associations between patient-reported outcomes and death or lung transplant in idiopathic pulmonary fibrosis. Data from the idiopathic pulmonary fibrosis prospective outcomes registry. Ann. Am. Thorac. Soc. 17, 699\u2013705 (2020).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"40508_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S2213-2600(17)30383-1","volume":"5","author":"M Kreuter","year":"2017","unstructured":"Kreuter, M. et al. Palliative care in interstitial lung disease: Living well. Lancet Respir. Med. 5, 968\u2013980 (2017).","journal-title":"Lancet Respir. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40508-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40508-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40508-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:14:33Z","timestamp":1700640873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40508-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40508"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40508-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13664"}}